Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Emre Yucel"'
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-11 (2021)
Abstract Effects of disease progression on healthcare resource utilization (HRU) and costs among multiple myeloma (MM) patients with ≥1 line of therapy (LOT) who received their first stem cell transplant (SCT) within 1 year of initial MM diagnosis
Externí odkaz:
https://doaj.org/article/ddc0f98d0a31440b99138b5c61872540
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-13 (2021)
Abstract Background Several options for granulocyte colony-stimulating factor (G-CSF) prophylaxis of chemotherapy-induced febrile neutropenia are available to patients worldwide. We have developed a novel patient-reported outcome measure, the Satisfa
Externí odkaz:
https://doaj.org/article/41ff44655bfb42f285232d082622f1d5
Publikováno v:
Preventive Medicine Reports, Vol 17, Iss , Pp - (2020)
Externí odkaz:
https://doaj.org/article/cbf06383ecb74fd1a7e977feab8d0180
Publikováno v:
Preventive Medicine Reports, Vol 10, Iss , Pp 248-253 (2018)
The purpose of this study was to determine the association between low-testosterone (total testosterone ≤3 ng/mL) and prevalence of kidney stones (KS) in men 20 years and older, and whether this varies by comorbidities, and race/ethnicity, and age.
Externí odkaz:
https://doaj.org/article/7e13d38a659f4de3bac4bd4ffaf3e89a
Publikováno v:
Advances in Therapy
Introduction Acute myeloid leukemia (AML) is associated with lower survival and greater unmet need compared with some other hematologic malignancies (HMs). Despite differences in acuteness between AML and other HMs, the burden of family caregivers (F
Autor:
Ryan K. Shields, Emre Yücel, Vladimir Turzhitsky, Sanjay Merchant, Jae S. Min, Alexandre H. Watanabe
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 37, Iss , Pp 190-194 (2024)
We assessed 160 patients who received imipenem/cilastatin/relebactam for ≥2 days. At treatment initiation, the median Charlson Comorbidity Index was 5, 45% were in the intensive care unit, and 19% required vasopressor support. The in-hospital morta
Externí odkaz:
https://doaj.org/article/2d2e2c9c66aa41bebe6f33db58030180
Autor:
Madeleine King, Véronique Sébille, Angelos P. Kassianos, Isoqol Proxy Task Force, Henrik Eshøj, Allan Berrocal, Emre Yucel, Jessica K Roydhouse, Katarzyna Wac, Rebecca Mercieca-Bebber, Claudia Rutherford, Alyssa M. Lanzi, Natasha Roberts, Nadia Corsini, Cindy J. Nowinski, Matthew L. Cohen
Publikováno v:
Roydhouse, J K, Cohen, M L, Eshoj, H R, Corsini, N, Yucel, E, Rutherford, C, Wac, K, Berrocal, A, Lanzi, A, Nowinski, C, Roberts, N, Kassianos, A P, Sebille, V, King, M T, Mercieca-Bebber, R & on behalf of the ISOQOL Proxy Task Force and the ISOQOL Board of Directors 2022, ' The use of proxies and proxy-reported measures : a report of the international society for quality of life research (ISOQOL) proxy task force ', Quality of Life Research, vol. 31, no. 2, pp. 317-327 . https://doi.org/10.1007/s11136-021-02937-8
Aims: Proxy reports are often used when patients are unable to self-report. It is unclear how proxy measures are currently in use in adult health care and research settings. We aimed to describe how proxy reports are used in these settings, including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53982020cdd1145626c97fb1f1713a6d
https://hdl.handle.net/11541.2/25632
https://hdl.handle.net/11541.2/25632
Autor:
Aysima Ince, Ersin Bayrakdar, Esra Nur Ince, Mehmet Ali Koç, Yunus Emre Yucel, Siyar Ersoz, Süleyman Utku Çelik, Cihangir Akyol, Hasan Gorkem Cay, Yasemin Celik
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-7 (2019)
BMC Gastroenterology
BMC Gastroenterology
Background Colorectal cancer (CRC) screening rates are low in the general population and among health care providers. The aim of this study was to evaluate the CRC screening practices of general surgeons who provide specialized diagnostic testing and
Background: Patients with multiple myeloma (MM) generally progress to being relapse/refractory (RR), having received several lines of treatment with various dosing frequencies and administration modalities, which impact patient satisfaction and exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d58761a96fb4fe51916c1feb0d21580d
https://doi.org/10.21203/rs.3.rs-459634/v1
https://doi.org/10.21203/rs.3.rs-459634/v1
Autor:
Nicola Bonner, Emre Yucel, Alejandro Moreno-Koehler, Kate Sully, Sumeet Panjabi, Andrew Trigg, Nina Shah, Kim Cocks, Claire Trennery
Publikováno v:
European journal of haematology, vol 103, iss 5
European Journal of Haematology
European Journal of Haematology
Objectives Thresholds for the minimally important difference (MID) or responder definition (RD) in health‐related quality‐of‐life (HRQoL) scores are required to interpret the impact of an intervention or change in the trajectory of the conditio